Asian Hospital and Medical Center signs MOU with Takeda to provide financial assistance programs for patients with rare diseases like Hodgkin lymphoma and multiple myeloma.

Precision for Medicine has launched a new office in Singapore, enhancing its APAC presence to seven locations and improving support for biomarker-driven clinical trials.

New guidance outlines integration of AI Act requirements into MDR quality management systems for European medical device manufacturers.

Encompass Health, the largest U.S. inpatient rehabilitation hospital operator, reported robust Q4 2025 results with 10.5% revenue growth and issued optimistic 2026 guidance following significant bed expansions.

The Asian Smart Medical Online Exhibition 2026, organized by AsianNet and TradeAsia, kicks off a four-month hybrid event aligning with global healthcare conferences to boost B2B medical trade.[1]

Epsilon Healthcare signs a three-year manufacturing agreement with Puro to produce GMP-certified pharmaceutical products for export to the UK and other European markets, projecting AU$2M revenue in 2026.

Healthcare analysts predict an increase in U.S. hospital mergers and acquisitions in 2026 following a slowdown in 2025, driven by policy clarity and financial pressures, though levels remain uncertain.[1]

Siloam Hospitals in Indonesia has installed the da Vinci Xi robotic-assisted surgery system, marking the first rollout of this advanced technology in the country to enhance surgical precision.

Flat Medical achieves major milestones with its EpiFaith Smart Syringe securing a framework agreement with UK NHS Supply Chain and a clinical order from Europe's largest hospital system AP-HP in France.

President Trump has signed a $1.2 trillion legislative package that includes sweeping pharmacy benefit manager reforms and continued funding for HHS, impacting hospital drug pricing and operations.